Hims, Super Bowl

Hims & Hers Super Bowl Spot Draws Drug-Industry Backlash
Telehealth provider Hims & Hers Health is defending its planned Super Bowl ad, which is styled as a political manifesto against weight-loss treatments priced “for profits, not patients,” after critici
Hims & Hers faces backlash over ‘misleading’ Super Bowl ad—but it didn’t stop stock from jumping over 11%
The telehealth company defended its ad with a defiant statement: ‘We’ve called out the system and now the system is asking that our ad get taken down.’ Telehealth company Hims & Hers Health is fighting back after the drug industry’s main lobbying group called out its first Super Bowl ad as “misleading” and in potential violation of marketing rules.
Hims & Hers Set To Run Impactful Super Bowl Ad
Telehealth company Hims & Hers' first Super Bowl ad is provocative and effective in building awareness of its weight loss offerings in a way that will generate buzz.
Hims & Hers faces scrutiny from senators on Super Bowl ad that ‘risks misleading' patients
Two U.S. senators wrote a letter to the Food and Drug Administration on Friday expressing concerns about an upcoming Super Bowl ad.
Hims and Hers Superbowl Ad Draws Controversy Over Safety
The GLP-1 compound drug sold by Hims and Hers is not approved by the FDA and its Super Bowl ad fails to list any risks associated with taking the medication.
Hims’ Super Bowl Ad Hit for ‘Misleading’ Weight-Loss Claims
A Super Bowl ad touting Hims & Hers Health Inc.’s copycat weight-loss drugs is getting pushback from the branded drugmakers’ lobbying group, which says it’s “misleading” and potentially violates marketing rules.
Lawmakers ask FDA to review Hims’ Super Bowl ad for ‘misleading’ patients
Two senators wrote to the FDA Friday about the Hims Super Bowl ad, which they said misleads patients about compounded weight loss drugs.
Hims & Hers Hopes Super Bowl Commercial About Obesity Stands Apart From Pack of Snacks
Hims & Hers, a tele-health start-up, aims to stand apart from dozens of Super Bowl commercials hawking snacks with a spot that discusses obesity
What the Hims Super Bowl Ad Is Really Selling
The Hims brand has primed people to view both their everyday health and the natural-aging processes as problems that can be tweaked and optimized—as if it were peddling operating-system updates for the human body.
IBD 50 Stock Hims & Hers Faces Backlash Over Provocative Super Bowl Ad
Hims stock surged into a profit-taking zone Friday after facing backlash over its provocative Super Bowl ad that criticized the makers of approved weight-loss drugs. On Friday, Sen. Richard Durbin (D-Ill.
Hims & Hers Super Bowl commercial draws lawmaker scrutiny
A TV commercial that the telehealth company Hims & Hers Health (NYSE:HIMS) is planning to run during the upcoming Super Bowl LIX coverage to promote its compounded weight loss products has drawn lawmaker scrutiny.
Drug industry groups target Hims & Hers Super Bowl ad touting weight loss drug
Drug industry calls out telehealth company Hims & Hers' Super Bowl ad touting its knock-off weight loss medications.
SF-based company airs controversial Super Bowl ad despite multiple objections
Hims & Hers, a San Francisco-headquartered telehealth company, ran its controversial Super Bowl commercial despite multiple ...
What is compounded semaglutide and is it safe? What Hims & Hers is selling, explained.
Compounded semaglutide is legal, but it's not regulated in the same way as medications like Ozempic and Wegovy.
Peninsula Daily News2d
Your Guide to Hims vs. Ro: A Research-Backed Review of ED Treatments
In today’s world, erectile dysfunction (ED) affects millions of men, causing emotional and psychological distress.
Hims & Hers stock price target according to the C&H pattern
Hims & Hers stock price continues to fire on all cylinders this year and is hovering near its highest level on record. It has ...